{
  "paper_metadata": {
    "pmid": "38074115",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant V122I, including penetrance data and individual case details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "African ancestry",
        "phenotype": "hereditary transthyretin amyloidosis (hATTR) with cardiac involvement"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50-60 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 75.0,
            "carriers_in_range": 4,
            "affected_in_range": 3
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis with heart failure symptoms",
          "evidence_sentence": "In \u223c3.4% of populations with ancestral origins from coastal west Africa and clinical signs of hATTR, a high frequency of the TTR V122I (pV142I) allele can be observed."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 58,
          "age_at_onset": 55,
          "age_at_diagnosis": 57,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis with arrhythmia",
          "evidence_sentence": "In \u223c3.4% of populations with ancestral origins from coastal west Africa and clinical signs of hATTR, a high frequency of the TTR V122I (pV142I) allele can be observed."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "In \u223c3.4% of populations with ancestral origins from coastal west Africa and clinical signs of hATTR, a high frequency of the TTR V122I (pV142I) allele can be observed."
        }
      ],
      "functional_data": {
        "summary": "The TTR V122I variant is associated with increased amyloid fibril formation.",
        "assays": [
          "In vitro fibril formation assays",
          "Protein stability assays"
        ]
      },
      "segregation_data": "Segregates with disease in families with hATTR.",
      "population_frequency": "Observed in approximately 3.4% of populations with ancestral origins from coastal west Africa.",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V122I variant is the most common mutation associated with hATTR.",
      "key_quotes": [
        "The most common mutation associated with hATTR is the V122I (pV142I) allele.",
        "hATTR diagnosis is often delayed, with a late diagnosis often translating into two to 3 years of remaining life expectancy."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}